Actively Recruiting
A Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of Pitavastatin/Ezetimib
Led by Boryung Pharmaceutical Co., Ltd · Updated on 2025-09-12
8606
Participants Needed
1
Research Sites
115 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate the efficacy and safety of fixed-Dose combination of Pitavastatin/Ezetimibe under the real-world condition
CONDITIONS
Official Title
A Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of Pitavastatin/Ezetimib
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Currently taking statins or statins with ezetimibe alongside diet and exercise for primary hypercholesterolemia or mixed dyslipidemia
- Judged to need fixed-dose combination of pitavastatin/ezetimibe due to statin formulation change, dose change, or addition of ezetimibe
You will not qualify if you...
- Currently taking a fixed-dose combination of pitavastatin/ezetimibe at study enrollment
- History of hypersensitivity or relevant medical issues related to pitavastatin or ezetimibe
- Participation in another clinical trial or use of investigational products within 12 weeks before enrollment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ewha Womans University Seoul Hospital
Seoul, South Korea
Actively Recruiting
Research Team
S
Shin-young Oh
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here